MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 13.10M | 10.04M | 11.97M | 14.91M | 13.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.10M | 10.04M | 11.97M | 14.91M | 13.12M |
| Cost of Revenue | 11.59M | 10.57M | 11.94M | 12.73M | 9.43M |
| Gross Profit | 1.51M | -527.00K | 29.00K | 2.18M | 3.69M |
| SG&A Expenses | 3.99M | 3.48M | 3.47M | 3.92M | 3.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.58M | 14.05M | 15.41M | 16.65M | 12.85M |
| Operating Income | -2.48M | -4.01M | -3.44M | -1.74M | 272.00K |
| Income Before Tax | -6.30M | -6.82M | -3.90M | -2.24M | 94.00K |
| Income Tax Expenses | -- | -48.00K | 32.00K | 7.00K | -- |
| Earnings from Continuing Operations | -6.30M | -6.78M | -3.93M | -2.25M | 94.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.30M | -6.78M | -3.93M | -2.25M | 94.00K |
| EBIT | -2.48M | -4.01M | -3.44M | -1.74M | 272.00K |
| EBITDA | -2.44M | -3.93M | -3.35M | -1.66M | 356.00K |
| EPS Basic | -0.19 | -0.20 | -0.12 | -0.07 | 0.00 |
| Normalized Basic EPS | -0.12 | -0.14 | -0.07 | -0.04 | 0.00 |
| EPS Diluted | -0.19 | -0.21 | -0.12 | -0.07 | 0.00 |
| Normalized Diluted EPS | -0.12 | -0.14 | -0.07 | -0.04 | 0.00 |
| Average Basic Shares Outstanding | 33.39M | 34.05M | 33.39M | 33.39M | 33.12M |
| Average Diluted Shares Outstanding | 33.39M | 34.05M | 33.39M | 33.39M | 45.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
